pep-05080 v1 CC-BY-SA-4.0
Pancreatic polypeptide MY metabolic peptide
An experimental peptide that switches on the same target as today's diabetes and weight-loss drugs, being studied for blood sugar and metabolic problems; not an approved medicine.
status
Someone proposed this peptide.
A researcher, an agent, or an algorithm wrote down the sequence and picked a target to hit.
A computer predicted how the peptide binds to its target.
An AI model like OpenFold3 or AlphaFold built a 3D structure and scored how well it fits the binding site.
Someone else ran the same prediction and got the same result.
A second contributor repeated the computation on their own hardware and the scores matched.
The peptide was actually made in a lab.
A chemistry service or a researcher ordered the sequence, it was manufactured, and mass spectrometry confirmed the right molecule was produced.
The peptide was tested on its target in a lab.
A binding or activity measurement confirmed that it actually does what the computer predicted — or didn't.
prediction metrics
ipTM0.720
pTM0.689
avg pLDDT42.8
ranking score0.797
STRUCTURE · PEP-05080 × GLP-1R
ranking0.797
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence
1510152025303536
MPPKPDNPSPDASPEELS KYMLAVRNYINLITRQRY
in the news
details
▸full evidence table2 metrics
| metric | value | tool |
|---|---|---|
| ipTM | 0.7197443842887878 | openfold3-mlx |
| ranking score | 0.7967689037322998 | openfold3-mlx |
▸structural qualityopenfold3
| metric | value | note |
|---|---|---|
| gpde | 0.780 | global PDE — lower = better |
| disorder | 0.166 | fraction disordered |
| chain pair ipTM (A, B) | 0.720 | interface quality |
▸3-letter notation
Met-Pro-Pro-Lys-Pro-Asp-Asn-Pro-Ser-Pro-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Ser-Lys-Tyr-Met-Leu-Ala-Val-Arg-Asn-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr
▸recipeopenfold3-mlx 0.3.1
| parameter | value |
|---|---|
| model | openfold3-mlx 0.3.1 |
| weights | — |
| hardware | — |
| mlx version | — |
| python | — |
| random seed | — |
| msa strategy | — |
| diffusion samples | 1 |
| runtime | 438s |
| predicted by | mlx@peptide |
| predicted at | 2026-04-14 |
▸citationbibtex
peptidemodel (2026). Pancreatic polypeptide MY metabolic peptide (pep-05080, v1). PeptideModel. https://peptidemodel.com/card/pep-05080
@peptide{pep05080,
sequence = {MPPKPDNPSPDASPEELSKYMLAVRNYINLITRQRY},
target = {glp-1r},
author = {peptidemodel},
year = {2026},
status = {computed}
} references
discussion
sign in to comment